Category survey

ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5 Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Effect of APOE on CNS Neurons: Role of LRP Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5 Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Language in Primary Progressive Aphasia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Alzheimers Abeta, apolipoproteins and blood-brain barrier Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Tau Conformation in Tauopathies and Neuronal Function Investments > €500k United States of America Neurodegenerative disease in general 2016    

Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Development of MRI microvascular biomarkers in cognitive impairment and dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

APP/APLP1/APLP2 in the brain Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Endothelial Dysfunction In The Cerebral Circulation Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

C9ORF72 in Motor System Biology and ALS Investments > €500k United States of America Motor neurone diseases 2016    

Memory network dysfunction as an early marker of preclinical Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

BACE1 in neurodegeneration and neuronal dysfunction Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Cell-Cell Signaling in Development and Regeneration of Visual Connections Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Presenilins and neuronal calcium dyshomeostasis Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

White Matter Connectivity and PD Cognitive Phenotypes Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Epitope-Specific Targeting of Tau Aggregates. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The hsp90 Cochaperone FKBP51 Regulates tau Structure and Function Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Life Enhancing Activities for Family Caregivers of People with Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Biomarkers for White Matter Injury in Mixed and Vascular Cognitive Impairment Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mechanism of Gene Environment Interactions in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Examination of the earliest symptoms and biomarkers of FTLD MAPT carriers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Alzheimers Medical Advisor: A Symptom and Sign Management Toolkit for Caregivers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mechanisms of brain phenotypes caused by FAD-linked Presenilin-1 Mutations Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Early and late-life metal exposures and Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Endogenous GABAergic Activity in the Mammalian Brain Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Molecular Genetic Characterization of SCA8 Investments > €500k United States of America Spinocerebellar ataxia (SCA) 2016    

Epigenetic Editing of Mutant C9orf72 Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

MicroRNA modulation of tau expression and phosphorylation in tauopathy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Optogenetic dissection of hippocampal circuitry underlying Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Role of PAR-1 Kinase in Synaptogenesis Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Neurophysiological Aspects of Vision-based Speed of Processing Cognitive Training in Older Adults with Mild Cognitive Impairment Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Beta-cell Function and Cognition in the Restoring Insulin Secretion (RISE) Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Clinical Utility of MicroRNAs as Diagnostic Biomarkers of Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Non-invasive Markers of Neurodegeneration in Movement Disorders Investments > €500k United States of America Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders 2016    

Molecular Basis of Synaptic Suppression by ApoE Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Altered Amyloid Processing HIV Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimers Dise Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Role of TFEB in Tauopathy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Prefrontal AMPA receptors in FTD Pathogenesis Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Dedicated Brain PET Device Optimized for Brain Imaging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

MRI and CSF Biomarkers of White Matter Injury in VCID Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Endothelial function of amyloid precursor protein Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The Role of Drosha in the Pathogenesis of Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Primary Progressive Aphasia: Cognition, Anatomy and Progression Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mechanisms and active compounds in the cognitive effects of Centella asiatica Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Biology of Native Alpha-Synuclein Tetramers in Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Mechanisms of age-related tauopathy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and AD Investments > €500k United States of America Alzheimer’s disease & other dementias 2016